Redefining BioPharma in a Female-Forward World

[Available On-Demand] ・ Click video to start playback;Join chat Q&A below video
Search General Info
The latest UN estimates show men slightly outnumber women globally, but the future of biopharma is female. As life expectancies increase, women clearly outnumber men at older ages, which means society is facing unprecedented healthcare challenges.

Hundreds of millions of women experience diseases that are in need of new therapies and improved access which translates to a new market opportunity, as evidenced by a recent BCC Research report which found these challenges are driving the women’s health market. Attendees will learn how the biopharma industry is uniquely positioned to address these challenges through a global approach.
Moderator
photo
Chief Medical Officer
WebMD
Speakers
photo
CEO
Gedeon Richter PregLem
photo
CEO
Daré Bioscience
photo
CEO
Mycovia Pharmaceuticals, Inc.
photo
President and Chief Executive Officer
Myovant Sciences